Ten Years for a $136 Million Telemedicine Scheme | What This Medicare Fraud Sentence Means for Florida Telehealth and DME Operators
Listen to Article
Part 1: Introduction
120 months, 66 million dollars in restitution, and the enforcement unit that secured it.
On June 30, 2026, a federal judge sentenced the owner of two telemedicine companies to 120 months in prison and ordered her to pay $66 million in restitution for a scheme that billed Medicare more than $136 million for braces and prescription drugs patients never needed. She was a licensed nurse practitioner. After her arrest, she rebranded herself as a compliance consultant and published books warning others how to avoid health care fraud. None of it changed the outcome. The sentence, and the unit that secured it, tell you where federal telehealth enforcement is heading in 2026.

The scheme ran from 2017 to 2019. Signed orders became inventory, sold to marketing companies for roughly $90 per beneficiary. The National Fraud Enforcement Division is now the unit charging these cases.
Key Takeaways
- A telemedicine company owner received 120 months and $66 million in restitution on June 30, 2026, for a $136 million Medicare fraud conspiracy.
- The conviction rested on conspiracy to commit wire fraud and health care fraud under 18 U.S.C. § 1349, § 1343, and § 1347.
- Selling signed orders to marketing companies for roughly $90 per beneficiary is conduct prosecutors charge as kickbacks under 42 U.S.C. § 1320a-7b.
- The National Fraud Enforcement Division now runs these prosecutions, and South Florida remains one of the busiest health care fraud districts in the country.
- Telemedicine and DME cases are usually won or lost in the pre-indictment window, before charging decisions harden.
What Actually Happened
According to the Justice Department's June 30 announcement, the defendant owned and operated two telemedicine companies between 2017 and 2019. Through those companies, she and others paid medical providers to sign orders for orthotic braces and prescriptions for Medicare beneficiaries who did not need them. She signed many of the prescriptions herself.
The signed orders then became inventory. She sold them to purported marketing companies for roughly $90 per beneficiary. The marketing companies resold the orders to brace suppliers and pharmacies, which billed Medicare for equipment and drugs that were never medically necessary. Practitioners working for her signed orders for four or more orthotics apiece for more than 3,000 beneficiaries. More than 40 beneficiaries had orders for ten or more braces. To hide the money, she used shell accounts and installed nominee owners for her companies. Medicare was billed over $136 million and paid over $66 million. Her husband was previously sentenced to seven years in a related $56 million scheme. The proceeds bought luxury vehicles.
She pleaded guilty in March 2024 to conspiracy to commit wire fraud and health care fraud. The detail that should stay with you is what happened between plea and sentencing. She held herself out as a legal consultant on medical billing and wrote compliance books. A decade in federal prison was the answer. Credentials acquired after the conduct do not buy leniency, and prosecutors used them to argue she understood exactly what the rules were.

What the Government Is Building in 2026
This case was prosecuted by the National Fraud Enforcement Division, the unit DOJ created on April 7, 2026 to consolidate fraud prosecutions nationwide. Its Health Care Fraud Unit and the strike forces under it have charged more than 6,200 defendants tied to over $45 billion in billings since 2007, and the pace is accelerating. Two weeks before this sentencing, the 2026 National Health Care Fraud Takedown charged 455 defendants on over $6.5 billion in alleged fraud, with a heavy Florida footprint that included a $27 million Medicare seizure in the Southern District of Florida and multi-defendant allograft cases in the Middle District.
The method matters as much as the numbers. These cases start with claims data, not tips. When Medicare data shows thousands of beneficiaries receiving four or more braces from a cluster of suppliers, agents work backward through the marketing companies to the telemedicine platform and the prescribers. Per-order payments between those layers are the government's roadmap. If your telehealth company, DME supply business, or marketing operation sits anywhere in that chain, the HHS-OIG enforcement pipeline is already looking at billing patterns like yours.

Exposure and Charges
The core statutes are health care fraud under 18 U.S.C. § 1347, which carries up to 10 years per count, wire fraud under 18 U.S.C. § 1343, which carries up to 20, and conspiracy under 18 U.S.C. § 1349, which carries the same penalty as the underlying offense. Per-beneficiary payments for signed orders bring the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), into play. Shell accounts and nominee owners invite money laundering counts under 18 U.S.C. § 1956.
Sentencing exposure is driven by the federal sentencing guidelines loss table, and the fight over whether loss means the $136 million billed or the $66 million paid can move a guideline range by years. Enhancements for sophisticated means, mass marketing, aggravating role, and abuse of a professional license stack quickly for a nurse practitioner or physician. Restitution is mandatory. Exclusion from federal health care programs follows conviction, and parallel civil liability under the False Claims Act, 31 U.S.C. § 3729, triples the damages. What the government must prove is knowing and willful participation in the scheme. Intent is where these cases are defended, which is why medical necessity documentation and what you actually knew about the marketing arrangements matter so much.
Critical Mistakes People Make Early
The same errors show up in nearly every telemedicine and DME file that crosses my desk. Talking to agents at your door without counsel, on the theory that cooperation now buys goodwill later. Responding to a CMS audit or an OIG subpoena as if it were routine paperwork, and locking yourself into a story before you know what the data shows. Continuing to bill the same codes after you know an audit is open. Assuming a written compliance manual protects you. This sentencing should end that last illusion. The defendant literally wrote books on health care compliance, and the government treated her expertise as proof she knew better. The worst mistake is waiting for an indictment to hire a federal criminal defense attorney, because by then the charging decisions are largely made.
Strategic Defense Approach
Effective federal investigation defense in these cases is front-loaded. Early engagement with the prosecutor can establish whether you are a witness, a subject, or a target, and can keep a subject from drifting into target status. There is often a real story to tell before charges: good-faith reliance on billing consultants, fair market value compensation for actual clinical work, safe harbor analysis under the Anti-Kickback Statute, and medical necessity evidence the data alone does not show.
If charges are coming anyway, the early window is where cooperation decisions, loss amount positioning, and role arguments get built. The gap between billed and paid amounts, the difference between the marketer who designed the scheme and the practitioner who signed orders, and the presence of legitimate patient encounters all change the guideline math. A white collar defense attorney who waits for the indictment to start that work has given up the most valuable ground in the case.

Why Timing Matters Right Now
The 2026 takedown seeded hundreds of follow-on investigations, and marketing company owners facing 20-year exposure are signing cooperation agreements and pointing up and down the chain. Telehealth platforms, prescribers, and DME suppliers named in those proffers are being charged in the second wave. If you have received a grand jury subpoena, a CID, a target letter, or even an unannounced visit from HHS-OIG or FBI agents about telehealth billing, the window to shape the outcome is open now and it closes without notice.

AMC Defense Law represents health care providers, telemedicine operators, and business owners in federal investigations and prosecutions in South Florida and nationwide.
Facing a federal telehealth, DME, or Medicare fraud investigation in Florida? AMC Defense Law represents health care providers, telemedicine operators, and business owners in federal investigations and prosecutions in South Florida and nationwide. If you have received a target letter, a grand jury subpoena, or a visit from federal agents, contact the firm for a confidential consultation before you respond to the government.
If you or your loved ones have been arrested or are under investigation for federal health care fraud, call Aaron M. Cohen, 24 hours a day to get help.
Listen to Article
Part 1: Introduction
120 months, 66 million dollars in restitution, and the enforcement unit that secured it.

Aaron M. Cohen
Principal Attorney
Aaron M. Cohen is a nationally recognized criminal defense attorney with over 30 years of experience representing individuals and entities in complex criminal investigations and prosecutions across the United States.
View Attorney ProfileRelated Analysis
A Six-Year Sentence for a Telehealth CEO: What the Done Global Adderall Case Means for Florida Digital Health Founders and Prescribers
On July 7, 2026, Done Global's founder received 72 months and a $1M fine for building a platform prosecutors called a drug distribution operation. Here is what it means for Florida.
DOJ Won Six Healthcare Fraud Trials in Three Weeks: What That Means If You Are Under Investigation in Florida
Between May 13 and June 1, 2026, the Justice Department's Health Care Fraud Unit won six federal jury trials involving more than $1.1 billion in fraud losses, including a $1 billion case out of Fort Lauderdale. The unit is now nine for nine at trial in 2026.
Super Clone Watches and Federal Charges | What Counterfeit Trafficking Prosecutions Mean for Florida Sellers
Selling high-grade replica watches feels like arbitrage. Federal law treats it as trafficking in counterfeit goods under 18 U.S.C. § 2320, with up to ten years per count. The enforcement pattern, the statutes, the sentencing math, and the pre-indictment window that decides these cases.